Company Snapshot

Investment Thesis

CooperCompanies develops contact lenses (CooperVision) and women's health fertility/obstetrics devices (CooperSurgical). Specialty lenses, myopia control, and fertility services drive recurring revenue.

  • Specialty Lenses: Clariti, Biofinity, and MiSight address daily silicone hydrogel and myopia.
  • Women's Health: Fertility solutions and surgical devices provide diversification.
  • Global Reach: Expanding distribution in Asia and emerging markets.

Strategic Mix

CooperVision Contact lenses
CooperSurgical Fertility, OB/GYN, diagnostics
Product Type Daily disposables, toric/multifocal, specialty
Geography Americas, EMEA, APAC

Mix mirrors Cooper's segment and product disclosures.

Recent Performance

MTD TBD
QTD TBD
YTD TBD
5Y TBD

Maxim is cueing up returns data for this security. Once the nightly supported.csv job runs, these metrics will auto-populate.

Strategic Insights

Myopia Management

MiSight approvals broaden adoption among pediatric patients.

Fertility Trends

Delayed family formation increases demand for IVF services.

Manufacturing Scale

Automated plants reduce unit costs as daily lenses mix grows.

Latest Coverage

Curated headlines sourced from Maxim’s AI newsroom.

Loading latest coverage...